Continuous ambulatory peritoneal dialysis and vitamin D

J. Rapoport, S. Shany, C. Chaimovitz

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Abstract

CAPD patients present special problems with respect to vitamin D metabolism. Because of substantial losses of vitamin D metabolites in the peritoneal dialysate, they require 2-3 times the oral replacement doses used in hemodialysis patients. Administration of 1,25(OH)2D3 or 1-alpha-OH-D3 should be sufficient to maintain normal levels of 1,25(OH)2D3, and to stimulate the renal production of 24,25(OH)2D3. However, anephric patients require, in addition, a source of 25OH-D3, in order to enhance extrarenal production of 24,25(OH)2D3.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalNephron
Volume48
Issue number1
DOIs
StatePublished - 1 Jan 1988
Externally publishedYes

Fingerprint

Dive into the research topics of 'Continuous ambulatory peritoneal dialysis and vitamin D'. Together they form a unique fingerprint.

Cite this